Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank New vaccine to protect people in the EU and worldwide against dengue 14 Οκτώβριος 2022NewsHumanMedicinesMedicines for use outside the EU High-quality data to empower data-driven medicines regulation in the European Union 10 Οκτώβριος 2022NewsHumanCorporateMedicines EMA Management Board: highlights of October 2022 meeting 7 Οκτώβριος 2022NewsCorporate Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022 7 Οκτώβριος 2022NewsVeterinaryMedicines Chair of the European Network of Paediatric Research at EMA re-elected 5 Οκτώβριος 2022NewsMedicinesPaediatrics Call for expression of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee 5 Οκτώβριος 2022News Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 Σεπτέμβριος 2022NewsCorporate New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 Σεπτέμβριος 2022NewsHumanMedicinesReferrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 Σεπτέμβριος 2022NewsHumanPharmacovigilanceReferrals EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 Σεπτέμβριος 2022NewsHumanAdvanced therapiesMedicines 1 … 39 40 41 42 43 Page 43 of 384 44 45 46 47 … 384
New vaccine to protect people in the EU and worldwide against dengue 14 Οκτώβριος 2022NewsHumanMedicinesMedicines for use outside the EU
High-quality data to empower data-driven medicines regulation in the European Union 10 Οκτώβριος 2022NewsHumanCorporateMedicines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022 7 Οκτώβριος 2022NewsVeterinaryMedicines
Chair of the European Network of Paediatric Research at EMA re-elected 5 Οκτώβριος 2022NewsMedicinesPaediatrics
Call for expression of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee 5 Οκτώβριος 2022News
Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 Σεπτέμβριος 2022NewsCorporate
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 Σεπτέμβριος 2022NewsHumanMedicinesReferrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 Σεπτέμβριος 2022NewsHumanPharmacovigilanceReferrals
EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 Σεπτέμβριος 2022NewsHumanAdvanced therapiesMedicines